Introduction
Most hematopoietic cells express Slamf6, which is one the of nine signaling lymphocyte activating molecule (SLAM) family receptors. Slamf6 expression is highest in activated T cells and B cells, whereas expression in dendritic cells (DCs) and macrophages can be induced by inflammatory signals (1) . Although Slamf6 signaling is extensively studied in adaptive immunity (2, 3) , less is known about the function of Slamf6 in innate responses.
Several Slam family glycoproteins serve as receptors for certain pathogens (Table 1) . For instance, human SLAMF1 is one of the receptors of Measles virus (4) . Slamf2 is a receptor for the lectin present on pili of certain enterobacteriaceae (5) . Recently, we found that Slamf1 can recognize the outer membrane porins OmpC and OmpF of Eschericia coli (6, 7) . Furthermore, most of the Slamf receptors modulate mechanisms that protect against microbial challenges mediated by signals that are induced by Slamf-Slamf homophilic ligation. For example in T cells and B cells, Slamf6 recruits SH-2-containing signal-transducing molecules to its intracellular intracellular tyrosine-based switch motives (ITSM) domains following homophilic ligation and receptor clustering, which is critically involved in germinal center reactions (3, 8) . Table 1 summarizes the susceptibility of Slam receptor-deficient mice to various infectious agents that have been used in to study Slamf functions.
Here, we assess whether Slamf6, like Slamf1, might be a microbial sensor for bacteria, especially E. coli and Citrobacter rodentium, which both reside in the gastrointestinal tract. Furthermore, enterohemorrhagic E. coli and enteropathogenic E. coli are attaching bacteria that harbor a pathogenicity island that renders them capable of colonizing colonic epithelia and causing lesions resulting in a compromised mucosal barrier (9) . They represent a major threat to global health, as they are responsible for a large number of cases of diarrhea that can be life threatening for infants and children. The closely related bacterium C. rodentium is a natural Gram − murine pathogen, and oral infection with this bacterium results in an infectious colitis characterized by local T h 1 responses, neutrophil and macrophage recruitment and epithelial hyperplasia. T cells and B cells are necessary for sterilizing immunity to C. rodentium and mice that lack CD4 + T cells have systemic dissemination of bacteria (9) (10) (11) .
To study the role of Slamf6 in innate immune responses, we employ Slamf6 −/− Rag −/− and Rag −/− mice, which solely rely on innate mechanisms to combat C. rodentium infections, because they lack T cells and B cells. The absence of T cells and B cells renders Rag −/− mice unable to mount an effective immune response to C. rodentium and the infection results in severe and ultimately fatal colitis (12) .
Roles for a range of innate cells have been implicated in the immunity against C. rodentium. Lamina propria CX 3 CR1 + macrophages are key in the early detection of the bacterium and specific depletion of these macrophages leads to enhanced pathologic inflammation and more systemic translocation (13, 14) . Upon activation, CX 3 CR1
+ macrophages produce IL-1β, IL-12 and IL-23 as well as other inflammatory mediators (14, 15) . The role of innate lymphocytes manifests predominantly through their production of IL-22, which contributes to mucosal protection by inducing the production of anti-microbial peptides and accelerating mucosal healing (16, 17) .
Here, we report that, surprisingly, Slamf6-deficiency renders Rag −/− mice resistant to C. rodentium-induced colitis, which suggests that Slamf6 negatively affects mucosal protection during colonic C. rodentium infection.
Methods

Mice
Slamf6
−/− C57BL/6J mice were described previously (18) . These mice were interbred with Rag1 −/− mice that were purchased from Jackson Laboratory (Bar Harbor, ME, USA). Ageand sex-matched wild-type (WT) and Rag1 −/− C57BL/6J mice were bred in-house and originally purchased from Jackson Laboratory. Mice were co-housed for at least 10 days prior to experimental use. All animals were maintained under specific pathogen-free conditions at the Center for Life Science animal facility of the Beth Israel Deaconess Medical Center (BIDMC) and were used at 8-13 weeks of age. The experiments were performed according to the guidelines of the Institutional Animal Care and Use Committee at BIDMC.
Evaluating bacterial binding by the IL-2 luciferase assay
Chimeric constructs, consisting of extracellular Ig domains of the Slamf6 receptor fused with the signaling competent cytoplasmic domain of CD3ζ, together with an IL-2 promoterdriven Firefly luciferase gene and Renilla luciferase under a mammalian promoter, are transfected into the Jurkat human T-cell line (6) . Six hours after transfection, heat-inactivated bacteria are added as stimulation and incubated overnight. Cells are washed and lysed according to the manufacturer's protocol (Dual Luciferase Reporter Assay, Promega, Madison, WI, USA). Substrates for Firefly luciferase and subsequently Renilla luciferase are added to 10 µl of the cell lysates and luminescence is measured using a standard Glomax luminometer (Promega). Values represent the ratio of Firefly and Renilla luminescence. 
In vivo bacterial infection by oral gavage
Citrobacter rodentium (DBS100) (ATCC#51459) was cultured in LB-broth for 4 h and washed in PBS prior to inoculation via oral gavage. Bacteria (2 × 10 9 ) were resuspended in 200 µl PBS, which was used for the inoculation of one mouse. The mice were monitored daily for morbidity and their weight was recorded every 3 or 4 days. Mice were sacrificed for analysis when their weight dropped below 80% of their starting weight or at the end of the experiment. Fresh stool pellets were collected in Eppendorf tubes for serial dilution in PBS and plating on MacConkey agar plates for quantification of colony forming units (CFU).
Treatment with an antibody directed against Slamf6
Rag −/− mice were intra-peritoneally injected with 100 µg antiSlamf6 mAb (330) 1 day prior to infection and subsequently every seventh day after the first injection. Control mice were injected with 100 µg mouse IgG2a in the same regimen. (19) .
Adoptive
Histology
Fresh colon tissue was harvested and fixed in paraformaldehyde (10%). Hematoxylin & eosin (H&E) staining was performed on slices of the proximal, medial and distal part of the colon. Scoring was performed by an independent pathologist (A.K.B.) assessing: (i) mononuclear cell infiltration, (ii) epithelial integrity, (iii) hyperplasia and (iv) edema.
Flow cytometry
Macrophages and DCs were incubated with anti-CD16/32 antibody to block Fc receptors at 4°C for 20 min. All samples were stained with relevant antibodies on ice for 30 min. Dead cells were excluded using 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI) (Roche, Indianapolis, IN, USA). The cells were acquired on a BD LSRII flow cytometer and the data analysis was performed using the FlowJo analysis package (Tree Star Inc., Ashland, OR, USA).
Cytokine analysis
Colons were harvested, washed in PBS with gentamycin (100 µg ml −1 ) and 100 mg tissue was cultured in 1 ml complete DMEM for 24 h. The amount of cytokines in the supernatant was analyzed using LEGENDplex reagents (Biolegend, San Diego, CA, USA) or CBA reagents (BD Biosciences, San Jose, CA, USA) according to the manufacturer's instructions.
Taqman quantitative PCR
Fresh colon tissue was collected, washed in PBS and homogenized by sonication in TRIzol reagent (Life Technologies, Grand Island, NY, USA). The vendor's protocol was followed for RNA purification. FAM/MGB 16sRNA probes were used as control housekeeping genes. Commercially available FAM/ MGB probes (Mm04203745_mH and Hs01011518_m1) were used for Iltifb (IL-22) and Il12b [IL-12(p70)], respectively (Life Technologies). Analysis was performed using the 7500 FAST Real Time PCR.
Statistical analysis
The Prism 5.0 software (GraphPad, San Diego, CA, USA) was used for results analysis. Results are reported as mean ± SEM. Most of the statistical comparisons were performed using the two-tailed Student's t-test. Values of P < 0.05 are considered to be statistically significant.
Results
Slamf6 engages in cognate interactions with several Gram − bacteria
To investigate a possible role of Slamf6 in innate immune responses during bacterial infections, we first assessed potential interactions between Slamf6 and Gram − E. coli, Salmonella typhimurium (SseB-), C. rodentium and the Gram + bacterium Staphylococcus aureus. To this end, we used a cell-based reporter assay based on co-transfection of a DNA segment encoding a chimeric Slamf6/CD3ζ together with an IL-2 promoter-driven luciferase gene into Jurkat cells (6) . Cognate interactions between the Ig domain of Slamf6 and bacterial surface entities result in increased luciferase activity. Using this assay, specific interactions between Slamf6 and E. coli and S. typhimurium (SseB-), but not between Slamf6 or S. aureus, were detected (Fig. 1A) . Citrobacter rodentium displayed binding to the ectodomain of Slamf6 (Fig. 1B ), albeit to a far lesser extent. Mutated E. coli that lack OmpC, OmpF or both lost the ability to interact with the ectodomain of Slamf6, suggesting that these bacterial proteins contain both the Slamf6-and Slamf1-interacting structures ( Fig. 1C) (6) . Further analysis of the interaction between Slamf6 and E. coli revealed that antiSlamf6 mAb blocked this interaction (Fig. 1D) .
Structural studies that assessed the formation of human SLAMF6-SLAMF6 homodimers revealed 13 amino acid residues that are critical for this interaction (20) . To evaluate whether these residues are also involved in bacterial interactions, we constructed three mutant Slamf6-CD3ζ chimeras at positions that affect homodimer formation (Fig. 1E ). These mutant Slamf6 molecules were capable of inducing a signal upon exposure to E. coli, suggesting that bacterial ligation does not involve amino acid residues that are essential in homodimer formation. Similar conclusions were made based upon the same type of analyses with mutants of human SLAMF6 and mouse Slamf1 (data not shown). Thus, the amino acids in the ectodomain of Slamf6 and Slamf1 that interact with structures in the outer cell wall of several Gram − bacteria are different from the amino acid residues, which are requisite for formation of the homodimers.
Stronger T h 17 response in Slamf6 −/− mice during C. rodentium infection
To evaluate the effect of Slamf6 on immune responses to bacteria, we selected C. rodentium, which is a well-studied model organism that induces intestinal inflammation. First, Slamf6 −/− and WT C57BL/6 mice were orally infected with
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2 × 10 9 C. rodentium bacteria and analyzed for progression of colitis. Upon infection, both colonic macrophages and a set of CD11c − cells express Slamf6 (Supplementary Figure 1A and B, available at International Immunology Online).
Slamf6
−/− mice, like WT mice, showed a slight reduction in their body weight on day 12 post-infection ( Fig. 2A) with a fecal C. rodentium burden of ~10 7 CFU per mg feces. The fecal burden steadily declined after day 16 and both WT and Slamf6 −/− mice appeared to recover from the infection (Fig. 2B and C) . Thus, Slamf6-deficiency has little impact on −/− T cells contained significantly more IL-17A upon stimulation with αCD3 mAb compared with WT culture supernatant, while IFNγ production was similar ( Fig. 3D and E) . Experiments in which colitis-inducing CD45RB hi CD4 + T cells were transferred to Rag −/− mice also showed that Slamf6 −/− T cells are more prone to IL-17A production (Fig. 3F) Fig. 3G and H) . Taken together, the data suggest that Slamf6 inhibits the production of IL-17A by CD4 + T cells. (Fig. 4D and E) . A loss in epithelial integrity as well as some inflammatory infiltration of mononuclear phagocytes was observed in Slamf6 −/− Rag −/− mice. In contrast, Rag −/− mice showed a strong reduction of epithelial integrity and more cellular infiltration, paired with submucosal edema (Fig. 4D) . This indicates that mucosal barrier damage and inflammation as a consequence of C. rodentium-induced colitis is reduced in Slamf6 −/− Rag −/− mice.
Citrobacter rodentium translocates to the spleen of both Rag −/− and Slamf6 −/− Rag −/− mice
One of the major differences in the early response to C. rodentium between Rag −/− and WT mice is the presence of mucosal CD4 + T cells. T h 1 cells localize at sites of bacterial lesions, produce IFNγ and aid in an early inflammatory response. However, T h 1 cells also contribute to immune pathology (10) (11) (12) 24) . T h 17 cells are required to contain C. rodentium and to prevent aberrant intestinal pathology (25) . Overall, the lack of T cells causes Rag −/− mice to develop a systemic multibacterial infection past the second week after oral infection due to this loss of colon barrier integrity (12) . Although pathologic features were significantly lower in Slamf6 −/− Rag −/− mice ( Fig. 4D and E) , C. rodentium was detected in splenic homogenates of these mice when cultured on MacConkey agar plates. However, more C. rodentium CFU were cultured from Rag −/− spleens (Fig. 4F) . Citrobacter rodentium systemic 
Reduced inflammation in Slamf6 −/− Rag −/− mice during C. rodentium infection
Having established that the absence of Slamf6 in T-cell-and B-cell-deficient mice improves the health of infected animals, Rag −/− mice showed an influx of phagocytes in the early progressive stage of a C. rodentium infection. As predicted from our histopathology analysis ( Fig. 4D and E Fig. 5A and B) . As judged by quantitative PCR of colon homogenates, a reduced production of the inflammatory cytokine IL-12(p70) was observed in the colons of Slamf6 −/− Rag −/− mice (Fig. 5C) 
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difference reduced to a non-significant level at day 6 postinfection, when IL-22 levels had dropped to 3-fold higher than those of uninfected mice (Fig. 6A and B) . As IL-22 is one of the key protective cytokines during C. rodentium infections, this observation may contribute to the reduced pathology and lower number of translocated bacteria in Slamf6 −/− Rag −/− mice (Fig. 4F ). As IL-22 production is driven primarily by IL-23, colon cultures were assessed for the production of this cytokine after C. rodentium infection. In contrast to the IL-12(p70) subunit of the IL-12 cytokine, Slamf6 −/− Rag −/− colons produced more IL-12/IL-23(p40) (Fig. 6C) Figure 1C , available at International Immunology Online) (14, 17) .
Administering a mAb directed against Slamf6 reduces C. rodentium colitis in Rag −/− mice
In order to test whether the anti-Slamf6 mAb, which inhibits the cognate interactions of Slamf6 with bacteria in the recognition assay (Fig. 1) , affects the bacterial colitis pathology, Rag −/− mice were intra-peritoneally injected with anti-Slamf6 or isotype (100 µg) 1 day before and every 7 days after C. rodentium infection (Fig. 7A) . Rag −/− mice that received the anti-Slamf6 mAb showed a delay in their weight loss, a reduction of fecal C. rodentium burden at the peak of infection and an increased survival rate (Fig. 7B-D) . These findings suggest that blocking the interaction of Slamf6 with bacteria reduces the pathology of C. rodentium-induced colitis.
Discussion
In this report, we provide evidence that Slamf6 −/− Rag −/− mice are markedly less susceptible to C. rodentium-induced colitis The balance between immune activation and mucosal protection is one of the defining factors in the pathogenic outcome of a C. rodentium infection. Whereas a range of key regulators of innate immune responses is indispensible for an effective response to C. rodentium, not all innate mechanisms are beneficial to the host. Several recent review articles discuss how innate receptors are involved in detection of C. rodentium (21, (26) (27) (28) . Two major receptor families mediate inflammatory signaling in response to C. rodentium: Tolllike receptors and Nod-like receptors, both of which utilize the NF-κB pathway. Interestingly, TLR4 signaling does not appreciably contribute to host protection against C. rodentium but rather enhances mucosal pathologic immune responses (29) . Contrary to this, TLR2 signaling promotes inflammatory responses as well as mucosal integrity (30, 31) . The authors of these studies argue that TLR4-mediated immune activation drives immune pathology during C. rodentium infections, which can be reduced by the protective function of TLR2 (27) . Along similar lines, an excess of IL-1β is detrimental to infected mice, whereas normal levels are required for an 
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appropriate response to C. rodentium (32) . From our data in Rag −/− mice, we conclude that Slamf6 also breaks tolerance and enhances inflammatory responses.
An interesting notion is that Slamf6 appears to affect the development of colitis only in Rag −/− mice. T cells and B cells play key roles in the development of an adequate immune response to C. rodentium. Mice that are impaired in their ability to mount a specific humoral response to the bacterium are unable to generate sterilizing immunity (11) . However, the protective role of CD4
+ T cells appears to be 2-fold: the direct protective effects of lesion-proximal T cells and eventually T-cell help to induce a sterilizing humoral immune response. µMT mice, which lack B cells, but have T cells, develop a milder colitis than Rag −/− mice (12) . Additionally, Rag −/− mice in which CD4 + T cells were adoptively transferred show more inflammation, but also better mucosal protection (22) . Both T h 1 and T h 17 cells have been implicated in the immune response to C. rodentium (21) . The lesions at sites of C. rodentium infections are associated with IFNγ-producing T h 1 clusters that contribute to the local response to the infection (10, 24 + colonic macrophages with C. rodentium result in the phagocytosis of the bacterium (14, 15, 33) . CX 3 CR1-deficient macrophages are impaired in their ability to probe the lumen of the intestine, which in WT as well as Rag −/− mice results in decreased IL-22 production and hence increased pathology of C. rodentium infection. Thus, interactions of colonic phagocytes with C. rodentium result in the production of IL-22 by phagocyte-proximal innate lymphocytes in Rag −/− mice (33). In another study, the role of IL-22 in the innate immunity to C. rodentium infection was clearly demonstrated utilizing an IL-22-specific antibody. Administration of this antibody to Rag −/− mice led to rapid weight loss, more severe colitis and expedited mortality (17) . Conversely, vitamin D receptor-deficient mice have higher numbers of ILC3 and produce more IL-22. Consequently, these mice have a reduced bacterial burden and lower immune activation (34) .
In this study, we report that Slamf6 interacts with several Gram − bacterial, including C. rodentium. Furthermore, Slamf6 −/− Rag −/− mice produce significantly higher amounts of IL-22 during C. rodentium infections. Higher levels of IL-22 result in stronger mucosal protection, thereby lessening epithelial damage (21) . We therefore speculate that engagement of C. rodentium by Slamf6 negatively affects phagocyte-induced signals that promote IL-22 production. Longman et al. (14) have shown that IL-23 and IL-1β production by phagocytes plays a role in the induction of IL-22 production by ILC3 cells. We report that infected colons of Slamf6 −/− Rag −/− mice produce less IL-12(p70) and more IL-12/23(p40). Thus, Slamf6 has important implications in the development of a colonic innate immune response to pathogenic Gram − bacterial challenge. Slamf6-deficiency in innate cells renders the outcome of C. rodentium-mediated immune activation more inflammatory and less protective, which profoundly affects the pathology and survival of Slamf6 −/− Rag −/− mice.
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